Abstract:Abstract Introduction Using cannabis as a sleep aid is common. However, little is known about how this practice relates to mental health and substance use. To address this, we examined associations between using cannabis as a sleep aid with mental health and substance use outcomes using a co-twin control design. Methods Participants were 3,165 adults (Mage=36.7 (SD=5.3)) from two population-based twin cohorts. Outcomes of interest included mental health constructs (e.g. depression, impulsivity), substance use measures (frequency and problems from use of specific substances), and use of other substances for sleep. First, we conducted regression models to test phenotypic associations between endorsing past month use of cannabis to aid sleep (yes/no) and the above outcomes. Next, we used multilevel models to examine whether significant phenotypic associations were due to between-family effects (genetic and environmental factors shared by co-twins) or within-twin pair effects (genetic and environmental factors which differ between co-twins). All analyses controlled for sleep quality and cannabis frequency. Results The sample was 56.7% monozygotic twins, 39.6% male, and 92.7% Caucasian. Phenotypic associations were significant between endorsement of using cannabis for sleep and most outcomes. All significant associations were in the direction of worse mental health, greater use of other substances for sleep, and greater frequency of, and problems from, substance use. All significant phenotypic effects remained significant at the between-family level, but not all remained significant at the within-family level. At the within-family level, the twin who endorsed using cannabis as a sleep aid (vs. their co-twin who did not) reported more frequent use of alcohol (B=0.44, p<.001) and medication (B=0.26, p=.022) for sleep, greater frequency of alcohol use (B=13.0, p=.018), and more problems from cannabis use (B=0.85, p=.007). Conclusion Associations between using cannabis for sleep with worse mental health, after controlling for sleep quality and cannabis frequency, are likely due to shared genetic and/or environmental factors. Associations with substance use measures that were not accounted for by shared genetic and/or environmental factors include greater alcohol use frequency, more problems from cannabis use, and more frequent use of other substances for sleep. Support (if any) DA042755, DA057894, DA053693, DA056408, DA032555, DA054212, MH125758 (NIH), 1101101 (ICR)

Prediction of suicidal thoughts and behaviors based on the diurnal cortisol pattern and THC dosage in continued cannabis users, a 5 year population-based matched cohort study

Adolescent exposure to Δ 9 -tetrahydrocannabinol alters the transcriptional trajectory and dendritic architecture of prefrontal pyramidal neurons

The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls

Quantity of delta‐9‐tetrahydrocannabinol consumption and cannabis use disorder among daily cannabis consumers

Predictors of perceived symptom change with acute cannabis use for mental health conditions in a naturalistic sample: A machine learning approach

Correlates of cannabis use and cannabis use disorder among adolescents with major depressive disorder and bipolar disorder in the National Comorbidity Survey-Adolescent Supplement (NCS-A)

Can the THC concentration predict the number of patients with cannabis‐related diagnoses?

Cannabis Use Characteristics Associated with Self-Reported Cognitive Function in a Nationally Representative U.S. sample

0995 Mental Health and Substance Use Outcomes Associated with Use of Cannabis as a Sleep Aid: A Co-twin Control Study

Event-level associations among THC, CBD, social context, and subjective effects during Cannabis use episodes

Cannabis use and its association with psychopathological symptoms in a Swiss adult population: a cross-sectional analysis

Observed Trajectories of Cannabis Use and Concurrent Longitudinal Outcomes in Youth and Young Adults Receiving Coordinated Specialty Care for Early Psychosis

Association Between Cannabis Use and Subjective Cognitive Decline: Findings from the Behavioral Risk Factor Surveillance System (BRFSS)

Cannabis cravings predict cigarette use in schizophrenia: a secondary analysis from two cannabis abstinence studies

Age-dependent association of cannabis use with risk of psychotic disorder

Cannabis use and neurocognitive performance at 13-14 Years-Old: Optimizing assessment with hair toxicology in the Adolescent brain cognitive development (ABCD) study

Incident psychotic experiences following self‐reported use of high‐potency cannabis: Results from a longitudinal cohort study

Associations of cannabis use, tobacco use, and incident anxiety, mood, and psychotic disorders: a systematic review and meta-analysis

Persistent increased severity of cannabis use disorder symptoms in adolescents compared to adults: a one-year longitudinal study

0400 Comparing the Effectiveness of Cannabis to Treat Sleep Impairments Between Those with and Without Sleep Disorders

The longitudinal association of cumulative depression with cannabis use disorder among young adults